Goldman Sachs set to pay €2 billion for Dutch pharma firm Synthon International

1 week, 1 day ago

BharatPe begins stake sale process in Unity SFB, appoints Rothschild

Mumbai: New-age non-bank lender BharatPe is looking to sell anywhere between 10% and 25% stake in Unity Small Finance Bank, depending on buyer interest, two people with knowledge of the development said. The agreement was struck at the time a consortium of Centrum Financial Services Ltd and BharatPe acquired the small finance bank licence. The first person added that Unity …

Finance Unity Bank Crore Pmc Rbi Small

3 weeks, 1 day ago

Senores Pharmaceuticals IPO raises ₹261 crore from anchor investors ahead of public issue

Live Mint

New Delhi, Dec 19 Senores Pharmaceuticals Ltd on Thursday said it has secured nearly ₹261 crore from anchor investors, ahead of its initial share-sale opening for public subscription. ICICI Prudential Mutual Fund, Mahindra Manulife Mutual Fund, Aditya Birla Sun Life Insurance Company, SBI General Insurance Company, and Troo Capital are among the anchor investors, according to a circular uploaded on …

Company Crore Pti Shares Ipo Senores Pharmaceuticals Senores

1 month, 4 weeks ago

AstraZeneca lifts guidance again as oncology drug sales soar to $5.6bn

Daily Mail

AstraZeneca has upgraded its annual guidance for the second time this year after sales of its cancer drugs soared in the third quarter. The pharmaceutical giant expects overall sales and core earnings per share to rise by a high-teens percentage at constant currency rates in 2024, having previously guided for low-teens percentage growth across both categories. Outlook: AstraZeneca has upgraded …

Sales Cent Drug Astrazeneca

5 months ago

Novo Nordisk shares sink after weight-loss drugs disappoint

Daily Mail

Shares in European pharma giant Novo Nordisk plunged on Tuesday after sales of a high-profile weight-loss drug disappointed in the second quarter. Titanic demand for the drugs and frenzied investor interest has driven Novo to become Europe's most valuable company, with its shares up by roughly 230 per cent since June 2021. The weight-loss drug market is forecast to be …

Cent Drug Quarter Novo

6 months, 4 weeks ago

Mankind Pharma in talks with PE for consortium bid of Bharat Serums: Report

Live Mint

Mankind Pharma is in talks with many private equity companies to form a joint bid to acquire Bharat Serums and Vaccines in a consortium, the Hindu BusinessLine reported, citing sources. Bain Capital, Blackstone, Carlyle, and KKR expressed interest in BSV after its current owner, Advent International, put it up for sale. While Mankind is in talks with these firms, the …

Blackstone Bsv

7 months, 3 weeks ago

AstraZeneca aims for $80 billion in total revenue by 2030

Hindustan Times

AstraZeneca aims to grow revenue by about 75% to $80 billion by 2030, it said on Tuesday, boosted by the expected launch of 20 new medicines and through growth in its existing oncology, biopharmaceuticals and rare disease portfolio. The Anglo-Swedish drugmaker had reported total revenue of $45.81 billion last year and earlier expected to launch at least 15 new medicines …

Billion Drug 2030

7 months, 4 weeks ago

Big tech companies investing in France

China Daily

By JONATHAN POWELL in London | China Daily Global | Updated: 2024-05-14 09:22 France's President Emmanuel Macron visits a McCain fries factory in Matougues, east of Paris on Monday as part of the Choose France summit. GONZALO FUENTES/POOL/AP France has announced a flurry of significant investments from tech titans Amazon and Microsoft, pharmaceutical giants Pfizer and AstraZeneca, and financial powerhouse …

France French Billion Paris Euros Morgan Stanley Pfizer

8 months, 3 weeks ago

Goldman Sachs Advises Shareholders To Sell And Buy Their Stakes In These Firms

News 18

Goldman Sachs was founded in 1869 and is a leading global investment banking, securities, and investment management firm. Meanwhile, Goldman Sachs has advised the shareholders to sell their shares in pharmaceutical company Laurus Labs Ltd. Goldman Sachs expects Syngene to benefit significantly from the China+1 trend due to its end-to-end service capabilities. These services include the improvement in biotech funding, …

China Services Stock Goldman Sachs Syngene Neuland

8 months, 4 weeks ago

Two brothers, a big biotech bet and an $8 billion payout

Live Mint

A two-decade bet on a biotechnology company turned into a roughly $8 billion windfall for investors in a New York hedge fund earlier this year. Baker Bros. Advisors, a hedge-fund firm run by brothers Felix and Julian Baker, had in 2003 invested in Seagen, a developer of next-generation cancer treatments. Baker Bros.’s flagship fund gained roughly 19% in 2023, some …

Investors Fund Billion Baker Firm Bros Felix

9 months, 3 weeks ago

PolicyBazaar’s parent PB Fintech to form a payment aggregator subsidiary

Live Mint

PolicyBazaar’s promoter PB Fintech on Wednesday said its board has approved the incorporation of a wholly-owned subsidiary for payment aggregator business. The new subsidiary called PB Pay Private Limited would “carry on the business of payment aggregator – domestic and / or cross border or both, as may be permitted by the Reserve Bank of India, by facilitating merchants with …

Fintech Crore Policybazaar Payment Aggregator Pb Fintech

9 months, 3 weeks ago

Vodafone agrees £6.8bn sale of Italian arm to Swisscom

The Independent

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. On Friday, London-listed Vodafone said the move represented an …

Business Italy Vodafone Swisscom

1 year ago

Bristol Myers Squibb acquires Karuna Therapeutics for $14 billion, boosting neuroscience portfolio

Associated Press

NEW YORK — Drugmaker Bristol Myers Squibb is acquiring Karuna Therapeutics, a biopharmaceutical company that has developed a new antipsychotic, in a $14 billion deal. “We expect KarXT to enhance our growth through the late 2020s and into the next decade,” Christopher Boerner, Bristol Myers Squibb CEO, said in a prepared statement, noting that the Karuna acquisition strengthens the company’s …

Billion Myers Bristol Bristol Myers Squibb Squibb Karuna Karxt

1 year ago

Bristol Myers Squibb acquires Karuna Therapeutics for $14 billion, boosting neuroscience portfolio

The Independent

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ …

Billion Email Myers Bristol Bristol Myers Squibb Squibb Karuna

1 year ago

Bristol Myers to Buy Karuna Therapeutics for $14 Billion

Live Mint

Drugmaker Bristol Myers Squibb reached a deal to buy neuroscience-drug developer Karuna Therapeutics for $14 billion. Bristol Chief Executive Christopher Boerner said the acquisition would accelerate the company’s efforts to establish a beachhead in neuroscience drugs and power new sales growth as its older products begin losing patent protection and face lower-price competition. Boerner said KarXT’s approval would be the …

Drugs Billion Drug Bristol Bristol Myers Karuna Therapeutics

1 year, 3 months ago

Torrent Pharma in talks with CVC, Bain Capital to raise funds for Cipla buyout

Live Mint

In a bid to raise funds for buying stake in Cipla, Torrent Pharmaceuticals is in talks with private equity funds CVC Capital Partners and Bain Capital. The Indian pharmaceutical is planning to raise up to $1.5 billion to bid for Cipla, reported Reuters citing sources familiar with the matter. Torrent and Blackstone are among those interested to acquire a stake …

India Indian Pharma Deal Reuters Blackstone Cipla

1 year, 5 months ago

Motherson acquires German polymer parts maker Dr Schneider for €118 million

Live Mint

New Delhi: In its second international acquisition this month, auto parts maker Samwardhana Motherson International on Monday said it will take over German high-end polymer parts maker Dr Schneider's business at an enterprise value of €118 million. "Samvardhana Motherson International Limited via its 100% subsidiary Samvardhana Motherson Automotive Systems Group BV has entered into an agreement to acquire assets and …

Interior Acquisition German Schneider Polymer Motherson Dr Schneider

1 year, 6 months ago

AstraZeneca plots to sell AI drug unit to the Chinese

The Telegraph

AstraZeneca’s pioneering artificial intelligence research centre could fall into foreign ownership under reported plans for the drugs giant to spin off and separately list its Chinese division. The Chinese division owns the company’s global research and development centre in Shanghai, as well as an “AI innovation centre” being developed there. There is a lot of investment, a lot of new …

Business China Company Chinese Ai

1 year, 9 months ago

UBS to buy Credit Suisse for $3.24bn in government-brokered deal

Al Jazeera

Authorities had been scrambling to rescue Credit Suisse before financial markets reopened on Monday. Switzerland’s largest bank, UBS, has agreed to buy Credit Suisse for 3 billion Swiss francs, officials from the banks have said, in a deal designed to contain a widening crisis of confidence in global finance. The agreement, announced late on Sunday, includes 100 billion francs in …

Credit Bank Ubs Credit Suisse Suisse Swiss Central

1 year, 11 months ago

BCL Industries to issue 55 lakh convertible bonds to raise funds

India TV News

BCL Industries has approved the issuance of convertible bonds to raise funds. The agro-based edible oil company through an exchange filing said that its board has approved over 55 lakh fully convertible bonds to promoter, non-promoter and public categories on a preferential basis. According to the company, the filing said, it aims to raise Rs 201,00,00,240 through convertible bonds. Meanwhile, …

Industries Convertible Bonds Bcl Bcl Industries

2 years, 1 month ago

Saraf And Partners Acts For Viatris In Its Sale Of Biosimilars Business To Biocon Biologics For US$ 3.335 Billion

Live Law

Global healthcare company - Viatris has, on November 29, completed the sale of its global biosimilars business to Biocon Biologics Limited, subsidiary of Biocon Limited for USD 3.335 billion for stock and cash consideration. The sale of global biosimilars business marks monumental moment to develop a future direction for Viatris that will not only unlock immediate value but will also …

India Deal Associate Partner Related Advised Biologics

2 years, 8 months ago

Q4 Results Preview: Margins of Pharma companies likely to remain under pressure in the March quarter

Live Mint

The Indian pharmaceuticals sector has been under pressure from the ongoing Russia-Ukraine war as a majority of pharma companies have a strong presence in both countries. The report estimates EBITDA in 4QFY22E to be sequentially lower for the majority of Indian generic pharma companies on account of lower gross margins due to an increase in raw material costs and sustained …

India Growth Russia Market Indian Companies Domestic

2 years, 10 months ago

Swiss Billionaire Hansjorg Wyss offered chance to buy Chelsea from Russian owner Roman Abramovich

Firstpost

Wyss, 86, who founded the medical device manufacturing firm Synthes, told the Swiss newspaper Blick that he and three others had been sounded out on Tuesday. Hansjorg Wyss, one of Switzerland’s richest men, said Wednesday he had been offered the chance to buy Chelsea, with the European football champions’ Russian owner Roman Abramovich under growing scrutiny. Abramovich revealed Saturday that …

Chelsea Johnson Billion Putin Russian Swiss Buy

2 years, 10 months ago

Biocon arm to acquire biosimilars business of Viatris for $3.34 bn

The Hindu

Biocon subsidiary Biocon Biologics Ltd has entered into a definitive agreement with its partner Viatris Inc to acquire Viatris’ biosimilars business for $3.34 billion. Kiran Mazumdar Shaw, executive chairperson of Biocon Biologics on Monday said BBL has entered into an agreement with Viatris to acquire its biosimilars business for $3.34 billion, which would include cash of up to $2.34 billion …

Billion Bbl Biocon Biocon Biologics Viatris Biosimilars

3 years ago

Société Générale bets $5.5 billion on car-leasing business

Live Mint

Société Générale SA’s vehicle-leasing business, ALD SA, agreed to acquire rival LeasePlan Corporation NV in a cash-and-share deal worth 4.9 billion euros, equivalent to $5.54 billion, the French bank said Thursday. Chief Executive Frédéric Oudéa said the new unit would eventually become a third pillar alongside the bank’s retail-banking and insurance business lines, as well as its corporate and investment …

Bank Société Société Générale Générale Business Ald Leaseplan

3 years, 4 months ago

Goldman Sachs’s Petershill plans London listing

Live Mint

Goldman Sachs Group Inc.’s Petershill Partners said Monday it plans to list an investment vehicle on the London Stock Exchange, taking advantage of a sizzling market for private equity. The London-based business, which invests in private equity and hedge fund firms that collectively manage $187 billion in assets, is tapping into global investors’ desire for juicy returns amid perennially low …

London Private Equity Billion Public Listing Petershill

3 years, 5 months ago

Low sugar foods and dairy alternatives to boom: Swiss firm

Live Mint

Health foods will become a dominant nutrition trend in the post-Covid era, the boss of the Swiss group Firmenich, one of the world's major flavour and perfume manufacturers, said. "We will invest disproportionately behind these two key trends," said Ghostine, without revealing any numbers. The company has two major divisions: flavours, supplying ingredients to the food industry, from small firms …

Billion Firm Swiss Ghostine Firmenich

3 years, 6 months ago

Former Morgan Stanley traders raise $100m to turn crypto startup into unicorn

The Independent

Sign up to our free weekly IndyTech newsletter delivered straight to your inbox Sign up to our free IndyTech newsletter Sign up to our free IndyTech newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy After a successful fundraiser, Amber Group, a Hong Kong-based cryptocurrency startup founded by …

Crypto Hong Kong Capital Indytech Morgan Stanley

3 years, 7 months ago

Premarket: The stock market after-party is in Europe

CNN

A version of this story first appeared in CNN Business’ Before the Bell newsletter. But Sacks thinks that after many years of “disappointment,” this could be Europe’s time to shine, resulting in a US-style wave of mergers and acquisitions and even a retail trading frenzy. “FDA will continue to monitor Aduhelm as it reaches the market and ultimately the patient’s …

Europe Space Cnn Billion Drug Bezos European

4 years ago

AstraZeneca buying drug developer Alexion for $39 billion

The Independent

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ …

Email Developer Alexion

4 years, 2 months ago

Novartis, Molecular Partners Ink Potential $230 Million Deal for Covid-19 Drug Candidates

News 18

Novartis has licensed global rights to two Molecular Partners’ antiviral drugs that have potential to treat COVID-19 patients, the two companies said on Wednesday. Molecular Partners will get an upfront payment of 60 million Swiss francs, a potential milestone payment of 150 million francs, and a “significant royalty” on sales of the drugs called MP0420 and MP0423. Previously, Molecular Partners …

Partners Drug Molecular Novartis Mp0420 Molecular Partners

4 years, 2 months ago

Blood company Sanquin to sell 85% of plasma operations to international investors

Dutch News

An ‘international consortium’ has reached a deal with Dutch blood company Sanquin to acquire 85% of its plasma products arm in the Netherlands and Belgium. ‘These have achieved cost savings and economies of scale that a national plasma-derived medicine manufacturer such as SPP cannot match,’ the company said in a statement. This requires a partnership.’ Small market ‘The Dutch market …

Medicine Dutch Blood Spp Plasma Company Sanquin

4 years, 8 months ago

Investors call on pharmaceutical firms to team up in Covid-19 fight

NL Times

Dutch and international investors are calling on the pharmaceutical industry to set profits aside and work together in the fight against Covid-19. About sixty investors signed a letter sent to the pharmaceutical companies they invest in on Thursday, NRC reports. "Patent enforcement, excessive pricing, concealing relevant research data and obtaining 'market exclusivity' should not stand in the way of," the …

Investors

5 years, 7 months ago

Fiat Chrysler puts merger offer to Renault board; deal to create a new third-ranked global manufacturer; shares rise

Firstpost

Fiat Chrysler has made a “transformative” merger proposal to Renault, the Italian-American carmaker said, in a deal that would create a new third-ranked global manufacturer Milan/Paris: Fiat Chrysler has made a “transformative” merger proposal to Renault, the Italian-American carmaker said, in a deal that would create a new third-ranked global manufacturer. The deal would create a carmaker selling 8.7 million …

France Italian French Deal Milan Merger Renault

Goldman Sachs set to pay €2 billion for Dutch pharma firm Synthon International

Discover Related